Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

Pathophysiology > Chapter 12 > Flashcards

Chapter 12 Flashcards

1
Q

Hallmark of AIDS and HIV

A
  • decrease in CD4+ (t-helper/introducer) lymphocytes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Epidemiology of AIDS

A
  • primary immunodeficiency caused by the retroviruses HIV type 1 and type 2
  • virus has continued to mutate and spread globally
  • increasingly becoming a disease of poor, uneducated, or undereducated people of color
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

HIV type 1

A
  • thought to have originated in central africa
  • cause of most AIDS cases found in central africa, US, Europe, Australia
  • has at least 10 subtypes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

HIV type 2

A
  • thought to have originated in west africa
  • found primarily in west africa
  • characterized by a longer latency/asymptomatic periosd, a milder form of the disease and lower mortality rates, can progress to AIDS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Transmission of AIDS

A

3 types

  • sexual (most common)
  • parenteral
  • perinatal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Parenteral

A

transmission via blood, blood products, or blood contaminated needles or syringes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

HIV (Human immunodeficiency Virus)

A

RNA retrovirus that causes defect in cell-mediated immunity that may progress to AIDS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Chemokine Coreceptors

A

must be present for the virus to gain entry into cells in order for the virion to fuse with the host cell

  • CCR5 must be present for HIV particles to bind to CD4+
  • CXCR4 must be present in later infection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Antiretroviral Therapy

A

This polydrug therapy approach
involves the administration of multiple antiretroviral agents. It provides
better viral suppression, thereby decreasing viral load, increasing
CD4+ counts, and decreasing resistance for a longer period.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

AIDS B cell changes

A

overproduction of nonessential anitbodies
antibodies are ineffective against diseases
increased apoptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

HIV disguises itself

A

with large amount of carbohydrate on surface of gp120

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Acute Infection oh HIV

A

HIV is widespread throughout body, with viremia and viral seeding of lymph tissures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Progression to asymptomatic phase

A

seeded HIV replicates in lymph nodes; graduly destroy’s lymph tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Verimia

A

virus enters the blood stream; recurs after lymph tissues are destroyed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

AIDS

A

is syndrome, the virus can express itself in multiple ways

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

HIV virion

A
  • enters body and quickly repllicates
  • present in the blood and cerebrospinal fluid
  • not detected by usual laboratory tests
  • usually asymptomatic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Seroconversion

A

the time in which enough HIV antibodies develop and become detectable in the blood
- occurs between 3 weeks to 6 months after exposure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Symptoms of primary HIV infection

A
  • flu or mono like symptoms
  • CD4+ t cell count greater thatn 400cells/ul
  • ## elevated ESR
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

ESR

A

erythrocyte sedimentation rate - a measurement of sedimentation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

CRP

A

C reactive protein - preferred test for inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Clinical latency period after seroconversion

A

ranges from 3 to 12 years

  • CD4+ cell count greater that 400/ul
  • virus is extremely active, producing up to 2 mil per day
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Rapid virus production after latency period

A

persistent and continuing drop in CD4+ T-cell count to less than 400/ul

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Symptomatic stage/chronic HIV infection

A
  • complete anergy, no response to skin testing
  • development of skin/membrane infections/problems
  • in children there are growth delays and they are frequently sick
24
Q

AIDS Diagnosis

A
  • CD4+ t cell count is less than 200/ul
  • one or more opportunistic infections
  • one or more tumors or cancers
  • most common symptoms are night sweats, fever, and nausea
25
Steps of HIV
infection of mucous tissue -> death of mucosal cd4+ cells -> Infection establishes in lymph tissues -> infection spreads throughout body -> immune response -> clinical latency -> AIDS
26
CD4+ T cell categories
Category A = count >or= 500ul Categoty B= count ranges from 200 to 499 Category C= count < 200
27
Clinical Category A
variety of clinical conditions, asymptomatic persistent generalized lymphadenopathy, history of or current acute HIV infection
28
Clinical Category B
conditions secondary to impaired cell mediated immunity
29
Clinical Category C
Conditions listed in AIDS surveillance case condition
30
ELISA (enzyme - linked immunosorbent assay)
- positive for HIV antibodies if blood or oral mucosal transudate of an infected person reacts with the surface antigen of killed HIV virus - highly sensitive and specific - must be performed with both HIV 1 and 2 viral antigens
31
Western Blot
- used when ELISA test is positive - used to confirm the presence of HIV - uses electrophoresis - identifies specific antibodies against the HIV protein antigen - specificity (combo'd with ELISA) > 99.9% - patient must wait 1-2 wks for confirmation
32
Absolute CD4+ cell count
- specific indicator of disease progression of HIV to AIDS
33
CD4+ lymphocyte percentage
<20% risk of AIDS development is higher
34
Plasma Viral Load
- indicates the amount of viral replication and the effectiveness of therapy - helps to predict disease progression - goal: to reduce viral load
35
Genotypic Resistance Testing
- identifies gene mutations | - very expensive
36
HAART Therapy
Highly Active Antiretroviral Therapy
37
Anergy/delayed hypersensitivity (type IV) test
- tests for M. tuberculosis, mumps, or measles viruses | - Early HIV: Skin test results normal
38
Megestrol acetate
a progestational agent; patients are at risk for blood clots in the legs
39
Dronabinol
antiemetic: decrease nausea and increase appetite
40
Systemic Manifestations of HIV/AIDS
-Malnutrition/wasting syndrome
41
Gastrointestinal Manifestations
- nearly universal in HIV infected people - chronic diarrhea is a Major GI complication (common cause is protozoa cryptosporidum) - candida albiacans infections
42
GI Symptoms
- chronic diarrhea - oral candidiasis - anorexia - nausea/vomiting - mucous membrane ulcers - retrosternal pain on swallowing - abdominal pain - low serum vitamin B12
43
Pulmonary Manifestations
- major source of morbidity/mortality in AIDS patients - opportunistic pneumonias - parenchymal lung diseases
44
Mucocutaneous Manifestations
- occur early and late in HIV - HIV viral exanthem is usually the first symptom - can have allergic, infectious, or neoplastic origin
45
Types of Mucocutaneuous manifestations
``` herpes zoster oral hairy leukoplakia Herpes simplex 1 & 2 S aureus Fungal skin infections Kaposi Sarcoma ```
46
Gynecologic manifestations
persistent monilial vaginitis, cervual dysplasia, cervical neoplasia, PID
47
Neurologic Manifestations
- neurologic system is invaded early | - primarily HIV encephalopathy
48
Ocular Manifestations
CMV retinitis | HIV associated retinopathy
49
Cardiovascular Manifestations
hypertriglyceridemia | lipidemia
50
Manifestations in other systems
renal impairment hematologic impairment liver dysfunction endocrine dysfunction
51
Major classes of Antiretroviral Therapt
nucleotide reverse transcriptase inhibitors (NRTIs) Nonnucleoside reverse transcriptase inhibitors (NNRTIs) Protease Inhibitors (PIs) fusion inhibitors Integrase strand transfer inhibitors (INSTIs) CCR5 antagonists
52
NRTIs
prevent HIV replication by preventing DNA synthesis
53
NNRTIs
inhibit reverse transcriptase do not need to be converted intracellularly potent antiretrovirals only given in combination with other antiretrovirals
54
Protease Inhibitors
inhibits protease that clips the viral protein precursors to the appropriate size extremely expnsive names typically end in "vir"
55
Fusion inhibitors
blocks fusion between viral and target cell membranes
56
CCR5 antagonists
blocks infection by blocking CCR5 and preventing HIV binding to cell membrane
57
Integrase transfer inhibitors
target and inhibit integrase encoded by the viral pol gene

Pathophysiology (34 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions